Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Repotrectinib Alone and in Combination with Immunomodulatory Drugs Exhibits Potent Anti-Multiple Myeloma Activity

Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson

Blood (2022) 140 (Supplement 1): 12460–12461.

https://doi.org/10.1182/blood-2022-167862

Published: 2022

Journal Articles

Ruxolitinib Enhances Anti-MM Function of Cytotoxic T-Cells By Upregulating IFNγ and Gzmb

Haiming Chen, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Charles David Deighton, Ning Xu, James R. Berenson

Blood (2022) 140 (Supplement 1): 12459.

https://doi.org/10.1182/blood-2022-167768

Published: 2022

Journal Articles

The JAK Inhibitor Pacritinib Suppresses the Checkpoint Proteins Pvrig and Tigit Expression on T Cells in Multiple Myeloma Patients

Ning Xu, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Charles David Deighton, Haiming Chen, James R. Berenson

Blood (2022) 140 (Supplement 1): 12458.

https://doi.org/10.1182/blood-2022-167320

Published: 2022

Journal Articles

Evaluation of Repotrectinib's Anti-MM Effects in Combination with Bortezomib, Carfilzomib, Cyclophosphamide, and Dexamethasone in Vitro and Ex Vivo

Haiming Chen, Eric Souther, Mingjie Li, Marissa-Skye Goldwater, Stacy Behare, Ava Hekmati, Huixin Yu, Isabella Nassir, Ariella Nassir, Ning Xu, James R. Berenson

Blood (2022) 140 (Supplement 1): 4213–4214.

https://doi.org/10.1182/blood-2022-169890

Published: 2022